Compare RLAY & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLAY | PWP |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2020 | 2020 |
| Metric | RLAY | PWP |
|---|---|---|
| Price | $9.59 | $17.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $16.86 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 2.5M | 691.9K |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | 31.78 | ★ 138.52 |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $31.87 |
| Revenue Next Year | $324.03 | $17.04 |
| P/E Ratio | ★ N/A | $37.23 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $1.78 | $14.44 |
| 52 Week High | $11.49 | $25.93 |
| Indicator | RLAY | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 41.30 |
| Support Level | $9.06 | $17.05 |
| Resistance Level | $11.46 | $20.33 |
| Average True Range (ATR) | 0.63 | 0.71 |
| MACD | -0.12 | 0.18 |
| Stochastic Oscillator | 16.18 | 61.84 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.